SEC Form 4/A · accession 0001645470-19-000002
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jun 15, 2015
Accepted (ET)
Jan 14, 2019 · 3:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2015 | P$0 | 19,226,657 | $0.00 | A | 19,226,657 | I | held by minor children and other entities |
| Common StockF1 | Jun 15, 2015 | P$0 | 329,466 | $0.00 | A | 19,556,123 | D | |
| Common StockF1 | Jun 20, 2016 | P$0 | 1,000,000 | $0.00 | A | 20,556,123 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.0189 | A | 20,566,123 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.0188 | A | 20,576,123 | D | |
| Common Stock | Jan 9, 2019 | P | 10,000 | $0.019 | A | 20,586,123 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,591,123 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,596,123 | D | |
| Common Stock | Jan 9, 2019 | P | 5,000 | $0.019 | A | 20,601,123 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Company grant